The First Department of Medicine, Wakayama Medical University, Wakayama, Japan.
J Diabetes Investig. 2011 Nov 30;2(6):474-82. doi: 10.1111/j.2040-1124.2011.00127.x.
Aims/Introduction: We have previously reported that the Pro198Leu missense polymorphism in the glutathione peroxidase 1 (GPx-1) gene was associated with frequent macrovascular disease (MVD). Our goal was to examine whether the GPx-1 genotype is associated with diabetic neuropathy.
We determined the GPx-1 genotype in 173 Japanese type 2 diabetic patients who received medical interviews, physical examinations, nerve conduction studies, quantitative vibratory perception (QVP), head-up tilt and heart rate variability tests by polymerase chain reaction-restriction fragment-length polymorphism. Diabetic sensorimotor distal symmetric polyneuropathy (DSPN) and diabetic autonomic neuropathy (DAN) were evaluated separately. DSPN and DAN were defined by two or more abnormalities of neuropathic leg symptoms, diminished Achilles tendon reflexes or impaired QVP in toes, and two autonomic dysfunctions, respectively. The association of the GPx-1 genotype with DSPN, DAN, MVD and other clinical manifestations was analyzed.
The prevalence of DSPN, impaired QVP and painful leg cramps in patients having a genotype with Pro/Leu at the codon 198 (Pro/Leu type) was significantly higher than those with Pro/Pro type. As a result of multivariate analyses that contained the GPx-1 genotype as an independent variable, the Pro/Leu type was extracted as a significant risk factor of DSPN, QVP impairment and MVD. The statistical significance did not disappear, even after proteinuria, retinopathy and a history of MVD were introduced as independent variables. In contrast, the GPx-1 genotype was not associated with DAN.
The Pro198Leu missense polymorphism of the GPx-1 gene might have a common genetic predisposition to DSPN and MVD. (J Diabetes Invest, doi: 10.1111/j.2040-1124.2011.00127.x, 2011).
目的/引言:我们之前曾报道过,谷胱甘肽过氧化物酶 1(GPx-1)基因中的 Pro198Leu 错义多态性与大血管疾病(MVD)的发生频率相关。我们的目标是研究 GPx-1 基因型是否与糖尿病神经病变相关。
我们通过聚合酶链反应-限制性片段长度多态性,在 173 名接受医学访谈、体检、神经传导研究、定量振动感知(QVP)、头高位倾斜和心率变异性测试的日本 2 型糖尿病患者中确定了 GPx-1 基因型。分别评估糖尿病感觉运动远端对称性多发性神经病(DSPN)和糖尿病自主神经病变(DAN)。DSPN 和 DAN 分别通过神经病性腿部症状的两项或更多异常、跟腱反射减弱或脚趾 QVP 受损,以及两项自主神经功能障碍来定义。分析了 GPx-1 基因型与 DSPN、DAN、MVD 和其他临床表现的关系。
在 198 密码子处具有 Pro/Leu 基因型(Pro/Leu 型)的患者中,DSPN、QVP 受损和腿部疼痛性痉挛的患病率明显高于 Pro/Pro 型患者。在包含 GPx-1 基因型作为独立变量的多变量分析中,Pro/Leu 型被提取为 DSPN、QVP 受损和 MVD 的显著危险因素。即使引入蛋白尿、视网膜病变和 MVD 病史作为独立变量,统计学意义仍然存在。相比之下,GPx-1 基因型与 DAN 无关。
GPx-1 基因的 Pro198Leu 错义多态性可能与 DSPN 和 MVD 具有共同的遗传易感性。(《糖尿病研究杂志》,doi:10.1111/j.2040-1124.2011.00127.x,2011 年)。